Transcoronary ablation of septal hypertrophy (Tash)

Indian Heart Journal

Volumn 58, Issue 4, 2006, Pages 371-374

  Sathyamurthy, I ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREATININE; PHOSPHOTRANSFERASE;

ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; COMPLETE HEART BLOCK; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE SEPTUM; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHY; LEFT CORONARY ARTERY; RISK FACTOR; STROKE; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT RESPONSE;

BALLOON OCCLUSION; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ANGIOGRAPHY; ETHANOL; HEART SEPTUM; HUMANS; HYPERTROPHY;

EID: 33845393617     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-14.
2. Kuhn H, Gietzen F, Leuner C, et al. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 1997;18:846-57.
3. Bahl V K, Chandra S, Chopra AK. Septal coronary artery ablation for hypertrophic obstructive cardiomyopathy. Ind Heart J 1996;48:701-3.
4. Bhargava B, Aggarval R, Kaul U, et al. Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy. Cathet Cardiovasc Diagn 1997;41:56-58.
5. Lakkis NM, Nagueh SF, Dunn JK, et al. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. One-year follow-up. J Am Coll Cardiol 2000;36:852-55.
6. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long-term follow-up of the first series of 25 patients. Heart 2000;83:326-31.
7. Lakkis N, Kleiman N, Killip D, et al. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol 1997;20:417-18.
8. Kuhn H, Gietzen FH, Leuner C, et al. Transcoronary ablation of septal hypertrophy (TASH). A new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 2000;89(Suppl 4):1V,41-54.
9. Singh M, Edwards WD, Holmes DR Jr, et al. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clinic Proc 2001;76:799-802.
10. Nayak R, Abraham O, Subramanyan K, et al. Anatomy of the first septal artery in hypertrophic obstructive cardiomyopathy patients. Ind Heart J 2005;57:524.
11. Faber L, Seggewiss H, Gleichmenn U, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998;98:2415-21.
12. Flores-Ramirez R, Lakkis NM, Middleton KJ, et al. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;37:208-14.
13. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hyptertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-55.
14. Veselka J, Aova SP, Duchonova R, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy; Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Cath and Cardiovasc Interv 2004;63:231-35.
15. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999;20:342-54.
16. Knight C, Kurbann AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation 1997;95:2075-81.
17. Seggewiss H, Fber L, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstruction cardiomyopathy. Thorac Cardiovasc Surg 1999;47:94-100.
18. Boekstegers P, Steinibigler P, Molnar A, et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:846-53.
19. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996;27:421-30.
20. Ruzyllo W, Chojnowska L, Demkow AM, et al. Left ventricular outflow gradient decrease with nonsurgical myocardial reduction improves exercise capacity in patient with hypertrophic obstructive cardiomypathy. Eur Heart J 2000;21:704-07.
21. Nayak HR, Subramanyan K, Abraham O, et al. Transluminal alcohol ablation for septal hypertrophy. Ind Heart J 2003;55:475.